DC Discussion Group
April 30, 2024
Rockville, MD, United States
In-Person
Contact: Mikaela Sanford
E-mail: msanford@casss.org
Phone: 510-428-0740
Host Cell Proteins (HCPs) – Risk-based Control Strategies for Established and Novel Therapeutic Biological Products
Location:
Institute for Bioscience and Biotechnology Research
9600 Gudelsky Dr.
Rockville, MD, USA
Join us in person at the IBBR campus where you can network with DC-area CASSS members. The April Discussion Group will be fully in-person. This DCDG session will discuss best practices to control HCPs for established recombinant protein products and challenges associated with HCP measurements for emerging cell and gene therapy products. In particular, we will discuss how to apply a risk-based approach and leverage prior knowledge to assure product quality and to meet regulatory expectations.